Molecular biology of rejection after liver transplantation

肝移植后排斥反应的分子生物学

基本信息

  • 批准号:
    14370350
  • 负责人:
  • 金额:
    $ 8.83万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2005
  • 项目状态:
    已结题

项目摘要

1.Hepatic warm ischemia-reperfusion injury (IRI) during hepatectomy and liver transplantation is a major cause of liver dysfunction in which the pathologic role of free radicals is a major concern. To assess the effect of MCI-186 (edaravone) on hepatic IRI, male Wistar rats were subjected to partial hepatic ischemia for 60 min after pretreatment with vehicle (group C) or MCI-186 (group M). Group M showed significantly lower levels of serum alanine aminotransferase and hepatic lipid peroxidation than group C, and also significantly lower expression levels of mRNA for cytokines, chemokines and intercellular adhesion molecule-1. There were fewer tissue monocytes and neutrophils in group M than in group C. Our findings suggest that treatment with MCI-186 attenuates hepatic IRI in this rat in vivo model.2.The mechanisms of Fas-Fas ligand (Fas-FasL)-mediated apoptosis in the pathogenesis of fulminant hepatic failure (FHF) have not been well defined. This clinical study was carried out to ass … More ess which cells expressed Fas-FasL and to determine their involvement. As the results, the numbers of TUNEL-, FasL-, and CD68-positive cells in the livers of patients with FHF were significantly larger than in those with CH or with normal livers. Double immunofluorescence staining showed that FasL was expressed predominantly on liver macrophages and rarely on CD8-positive lymphocytes. Macrophages and their expression of FasL may play roles in the pathogenesis of FHF.3.We selected sublines with a high capability for differentiation to contracting cardiomyocytes and also produced germ-line chimeric mice from a parent ES line. We also succeed in establishing embryoid bodies prepared from the ES cells that differentiated into not only hepatocytes but also at least two mesodermal lineages : cardiomyocytes that supported liver development and endothelial cells corresponding to sinusoids. The expression of albumin was significantly higher in cardiomyocytes that had arisen in differentiated ES cells than in those that had not. Our in vitro system for liver organogenesis consists of a blood/sinusoid vascular-like network and hepatocyte layers and shows higher levels of hepatic function, such as albumin production and ammonia degradation, than hepatic cell lines and primary cultures of murine adult hepatocytes. This innovative system will lead to the development of second-generation regenerative medicine techniques using ES cells and is expected to be useful for the development of bioartificial liver systems and drug-metabolism assays. Less
1.肝脏和肝移植期间的肝脏温暖缺血 - 再灌注损伤(IRI)是肝功能障碍的主要原因,其中自由基的病理作用是主要问题。为了评估MCI-186(Edaravone)对肝脏IRI的影响,在用媒介物(C组)或MCI-186(M组)预处理后,将雄性Wistar大鼠患有部分肝缺血60分钟。 M组显示出明显低于C组的系列丙氨酸氨基转移酶和肝脂质过氧化水平,而细胞因子,趋化因子和细胞间粘附分子1的mRNA表达水平也明显较低。在M组中,组织单核细胞和中性粒细胞的少于C组。我们的发现表明,MCI-186的治疗在这种大鼠体内模型中减弱了肝IRI。这项临床研究是为了进行屁股……更多的ESS细胞表达FAS-FASL并确定其参与。结果,FHF患者生活中TUNEL-,FASL-和CD68阳性细胞的数量明显大于CH或正常寿命的细胞。双重免疫荧光染色表明,FASL主要在肝巨噬细胞上表达,很少在CD8阳性淋巴细胞上表达。巨噬细胞及其表达FASL可能在FHF的发病机理中起着作用。3。我们选择的subline具有很高的分化能力与收缩心肌细胞的能力,并且还从父级ES系列产生了种系嵌合小鼠。我们还成功地建立了从ES细胞制备的胚胎体,这些ES细胞不仅分化为肝细胞,而且至少有两个中胚层谱系:支持肝脏发育和与正弦曲线相对应的内皮细胞的心肌细胞。在分化的ES细胞中产生的心肌细胞中白蛋白的表达明显高于没有的细胞。我们用于肝脏器官发生的体外系统由血液/正弦血管状的网络和肝细胞层组成,并显示出比肝成年成人肝细胞的肝素细胞系和原发性培养的肝素功能,例如白蛋白产生和氨降解。这种创新的系统将导致使用ES细胞的第二代再生医学技术的发展,并有望有助于生物人工肝脏系统和药物代谢测定法的开发。较少的

项目成果

期刊论文数量(93)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Characterization of cytochrome P450 expression in murine embryonic stem cell-derived hepatic tissue system
  • DOI:
    10.1124/dmd.105.007674
  • 发表时间:
    2006-04-01
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Tsutsui, M;Ogawa, S;Tagawa, YI
  • 通讯作者:
    Tagawa, YI
Hashikura Y, Ikegami T, Nakazawa Y, 他: "Delayed domino liver transplantation: use of the remnant liver of a recipient of a temporary auxiliary orthotopic liver transplant as a liver graft for another patient"Transplantation. 77. (2004)
Hashikura Y、Ikegami T、Nakazawa Y 等人:“延迟多米诺肝移植:使用临时辅助原位肝移植受者的剩余肝脏作为另一名患者的肝移植物”77。(2004 年)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Living donor liver transplantation : issues regarding left liver grafts
活体肝移植:有关左肝移植的问题
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hashikura Y;Kawasaki S
  • 通讯作者:
    Kawasaki S
Mita A, Hashikura Y, Momose M他: "Usefulness of albumin scintigraphy in a pediatric liver transplant recipient with gastrointestinal posttransplant lymphprolifcrative disorder"Liver Transpl. 8(6). 568-569 (2002)
Mita A、Hashikura Y、Momose M 等人:“白蛋白闪烁扫描在患有胃肠道移植后淋巴增殖性疾病的儿科肝移植受者中的作用”Liver Transpl. 8(6) (2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
肝癌に対する生体肝移植-ドミノ肝移植
活体肝移植治疗肝癌 - 多米诺肝移植
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    浦田浩一;橋倉泰彦;池上俊彦;中澤勇一;寺田克;宮川眞一
  • 通讯作者:
    宮川眞一
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HASHIKURA Yasuhiko其他文献

HASHIKURA Yasuhiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HASHIKURA Yasuhiko', 18)}}的其他基金

Study on the role of Fas/Fas ligand related apoptosis in the liver transplant recipients
Fas/Fas配体相关细胞凋亡在肝移植受者中作用的研究
  • 批准号:
    11470242
  • 财政年份:
    1999
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
EXPERIMENTAL AND CLINICAL STUDY ON AN NOVEL STRATEGY AGAINST HEPATIC ARTERY THROMBOSIS AFTER LIVER TRANSPLANTATION
肝移植后抗肝动脉血栓新策略的实验和临床研究
  • 批准号:
    08457297
  • 财政年份:
    1996
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

m6A甲基化修饰FDX1介导铜死亡参与心肌缺血再灌注损伤的机制研究
  • 批准号:
    82302465
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于TRIM27/MST4/ATG4B通路激活自噬流减轻肠缺血再灌注损伤致肠屏障功能障碍的机制研究
  • 批准号:
    82302467
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
神经干细胞外泌体传递YBX1调控ANXA2稳定性缓解脑缺血再灌注损伤机制研究
  • 批准号:
    82360386
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
RNA甲基化转移酶METTL7B介导lncRNA-MIR22HG的m6A修饰促进脑缺血再灌注损伤的机制研究
  • 批准号:
    82301476
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
15-脂氧合酶及其代谢产物15-HpETE在缺血再灌注损伤诱发心肌细胞铁死亡过程中的调控作用和机制研究
  • 批准号:
    82370295
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Preoperative exercise therapy for surgery triggered inflammation
手术前运动疗法引发炎症
  • 批准号:
    10701043
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Investigating siRNA-mediated inhibition of ischemia-reperfusion injury during the liver transplantation process
研究肝移植过程中 siRNA 介导的缺血再灌注损伤抑制作用
  • 批准号:
    10740842
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Preoperative exercise therapy modulates neutrophil extracellular trap formation
术前运动疗法调节中性粒细胞胞外陷阱的形成
  • 批准号:
    10810353
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
A microphysiological system with a synthetic hemoglobin, Blood Substitute, for mechanistic assessment of drug-induced liver injury
具有合成血红蛋白(血液替代品)的微生理系统,用于药物性肝损伤的机械评估
  • 批准号:
    10385048
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Preoperative exercise therapy for surgery triggered inflammation
手术前运动疗法引发炎症
  • 批准号:
    10684527
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了